首页> 外文期刊>Cytometry, Part B. Clinical cytometry: the journal of the International Society for Analytical Cytology >One-Tube HLA-B27/B2708 Typing by Flow Cytometry Using Two 'Anti-HLA-B27 Monoclonal Antibody Reagents
【24h】

One-Tube HLA-B27/B2708 Typing by Flow Cytometry Using Two 'Anti-HLA-B27 Monoclonal Antibody Reagents

机译:使用两种“抗HLA-B27单克隆抗体”试剂通过流式细胞术进行单管HLA-B27 / B2708分型

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Flow cytometry-based methods are widely used to detect the ankylosing spondylitis-associated HLA-B27/B2708 antigens. However, the generally used "HLA-B27" monoclonal antibodies (moabs) cross-react with many HLA specificities, including the common HLA-B7 antigen. Thus, using two "B27" moabs is highly recommended. Methods: The assay used two "HLA-B27" reagents, FITC and PE conjugated, respectively and a PE-Cy5 anti-CD3 antibody. Assay verification used 51 reference subjects possessing B*2705, B*2702, and B*2708 and a range of cross-reactive HLA antigens. A total of 1,006 consecutive patients' samples, referred for "HLA-B27 typing", were assayed alongside our standard flow cytometry method. A further 12 low frequency HLA-B*27 specificities were tested. Samples reacting with one "B27" moab only were B*27 allele typed by PCR using sequence-specific primers. Results: All patient B27/B2708 positives (28.3%) were identified by our one-tube method which detected B*2705, B*2702, B*2708, and 8/12 other B*27 specificities. It was unaffected by HLA-B7 and other cross-reactive antigens but required a minor adjustment, a reduction in the volume of one of the "B27" moabs used, to avoid detecting a minority of HLA-B57 subjects. Conclusions: Our one-tube B27/B2708 assay is simple, robust, uses two "B27" moabs for typing precision and security, does not suffer from interference by HLA-B7 or other cross-reactive antigens and has the obvious advantage of using a single tube per typing.
机译:背景:基于流式细胞仪的方法被广泛用于检测与强直性脊柱炎相关的HLA-B27 / B2708抗原。但是,通常使用的“ HLA-B27”单克隆抗体(moab)与许多HLA特异性(包括常见的HLA-B7抗原)发生交叉反应。因此,强烈建议使用两个“ B27”摩押。方法:该测定法使用两种“ HLA-B27”试剂(分别与FITC和PE偶联)和一种PE-Cy5抗CD3抗体。分析验证使用了51位参考受试者,他们具有B * 2705,B * 2702和B * 2708以及一系列交叉反应性HLA抗原。与我们的标准流式细胞仪方法一起,共检测了1,006个连续的患者样品,称为“ HLA-B27分型”。测试了另外12种低频HLA-B * 27特异性。仅与一个“ B27” moab反应的样品是使用序列特异性引物通过PCR鉴定的B * 27等位基因。结果:通过我们的单管方法鉴定了所有患者B27 / B2708阳性(28.3%),该方法检测到B * 2705,B * 2702,B * 2708和8/12其他B * 27特异性。它不受HLA-B7和其他交叉反应性抗原的影响,但需要进行较小的调整,即减少使用的“ B27”颗粒之一的体积,以避免检测到少数HLA-B57受试者。结论:我们的单管B27 / B2708检测方法简单,稳健,使用两个“ B27” moab进行打字以确保准确性和安全性,不受HLA-B7或其他交叉反应性抗原的干扰,并且具有使用单抗的明显优势。每次打字单管。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号